Wildflower New York Charter School
Analysis
Wildflower New York Charter School is a registered charity in United States, based in Bronx, NY. It received its IRS tax-exemption ruling in March 2020, 6 years ago. Its declared purposes cover education, which this site groups under education and training. The IRS classifies it as a school under section 501(c)(3), and contributions to it are listed as tax-deductible.
In the financial year ending June 2023, Wildflower New York Charter School reported income of $1.7m and spending of $1.4m, spending 85% of its income. Across the 3 years on record, from June 2021 to June 2023, income grew from $946k to $1.7m (+75%), an average of +32% a year. The sharpest change came in the year to June 2023, when income rose by 36%. Over the whole period it spent 88% of the income it received.
Among 66,972 United States charities whose main cause is education and training and that reported income, Wildflower New York Charter School sits at the 81st percentile: it is larger than about 80% of them. Against every charity in United States with reported income it ranks in the 84th percentile, and in the 81st percentile within NY. Charities of a similar size with the same main cause include Lafontaine Preparatory School II Inc ($1.7m), Residential Revival Indiana ($1.7m) and Stone Valley Community Charter School Inc ($1.7m).
On its Form 990 for the period ending June 2023, revenue came from contributions and grants 100% of the total. Compensation of current officers, directors and key employees was $282k (20% of expenses). Other salaries and wages came to $347k. At year end it held assets of $736k against liabilities of $285k, net assets of $452k. It reported 9 employees.
Income and spending
Where the income comes from
- Contributions & grants 100%
- Other 0.0%
Similar-sized charities, same cause
| Charity | Location | Income |
|---|---|---|
| Lafontaine Preparatory School II Inc | Richmond | $1.7m |
| Residential Revival Indiana | Indiana | $1.7m |
| Stone Valley Community Charter School Inc | Huntingdon | $1.7m |
| Biotech Partners | Emeryville | $1.7m |